LifeMD, Inc. revenue by segment LFMD

LifeMD, Inc. splits its revenue into 4 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Telehealth Subscription Revenue at $113.3 million, 58% of the total.

USD in millions. The percent under a figure is the change from the year before.

Line
FY 2026
Jun 30, 2026
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
FY 2019
Dec 31, 2019
FY 2018
Dec 31, 2018
FY 2017
Dec 31, 2017
FY 2016
Dec 31, 2016
Revenue
192
194
155
153
119
93
37
12
8
4
5
Telehealth Subscription Revenue
114
+8.0%
share 59.4%
113
+67.3%
share 58.4%
68
+1486.5%
share 43.7%
4
share 2.8%
—
—
—
—
—
—
—
Telehealth
78
-4.1%
share 40.6%
81
-1.6%
share 41.6%
82
-11.8%
share 53.1%
93
+12.7%
share 61.1%
83
share 69.4%
—
—
—
—
—
—
Work Simpli
—
—
54
-0.7%
share 34.9%
54
+49.5%
share 35.7%
36
share 30.6%
—
—
—
—
—
—
Medifast Collaboration Revenue
—
—
5
+0.0%
share 3.2%
5
share 3.3%
—
—
—
—
—
—
—
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry
Services-Offices & Clinics of Doctors of Medicine (SIC 8011)
Listed as
LFMD (Nasdaq), LFMDP (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Accelerated filer
SEC CIK
948320
Former names
CONVERSION LABS, INC. (until Feb 22, 2021); Immudyne, Inc. (until Jun 19, 2018)

Other Services-Offices & Clinics of Doctors of Medicine companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.